Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics

The distinguished translational oncology researchers on Unum’s Scientific Advisory Board (SAB) provide counsel to support continued development of our ACTR platform, and provide us with key insights as we develop our broader research agenda. Comprised of pioneers in immuno-oncology, our SAB includes:

 

 

Dario Campana, MD, PhD
Chair

Bio

 

Malcom Brenner, MD, PhD

Bio

 

John Gribben, MD, DSc, FRCP, FRCPath, FMedSci

Bio

 

Crystal Mackall, MD

Bio

Malcolm Brenner, MD, PhD

 

Dr. Brenner’s career has focused on gene therapy and cancer-related immunotherapies, including genetic-modification of T cells. He is currently the founding director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist Hospital and Texas Children’s Hospital. In his prior work at St. Jude Children's Research Hospital, he conducted one of the first human gene therapy studies, using a retroviral vector to transduce bone marrow stem cells. He has also served as President of the International Society for Cellular Therapy; President of the American Society of Gene Therapy; and Editor-in-Chief of the journal Molecular Therapy.